본문내용 바로가기


AI LIFECARE(Digital BioHealth)

Electroceuticals
Technology that treats (relieves) immune and metabolic-related diseases by stimulating neural circuits with electricity, light, and ultrasound to regulate metabolic functions (‘Electroceuticals’ is the compound word ‘Electronic’ and ‘Pharmaceutical’).
Technical overview

Technology that improves human function and treats diseases by controlling nerves, metabolism, and body functions by applying energy such as light, electricity, magnetic field, etc. to the human body through non-invasive, minimally invasive, and human insertion

Necessity and importance

(Markets) The global electronic drug market is expected to grow 11.2% annually from $3.3 billion in 2019 to $6.2 billion in 2024

(Policies) The government is fostering the field through the designation of BIG3 industries and strategies to promote the commercialization of the biohealth industry ('20), and is providing institutional support with the Medical Device Industry Promotion Act, in vitro diagnostic medical device method, and advanced regenerative medicine and advanced biopharmaceutical safety and support

Applications

<   Electroceuticals  device  application  field   >

Areas Description
Brain/neurological disease

Mental illness such as Alzheimer's disease, Parkinson's disease, depression, etc.

Immune disease

Rheumatoid arthritis, etc.

Metabolic disease

Obesity, high blood pressure, diabetes, etc.

Chronic pain

Migraine, musculoskeletal pain, menstrual pain, etc.

Cancer disease

Brain tumors, lung cancer, etc.